These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase. Li C; Nicolau DP; Lister PD; Quintiliani R; Nightingale CH J Antimicrob Chemother; 2004 Feb; 53(2):297-304. PubMed ID: 14729755 [TBL] [Abstract][Full Text] [Related]
11. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase. Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711 [TBL] [Abstract][Full Text] [Related]
12. Assays for beta-lactamase activity and inhibition. Viswanatha T; Marrone L; Goodfellow V; Dmitrienko GI Methods Mol Med; 2008; 142():239-60. PubMed ID: 18437319 [TBL] [Abstract][Full Text] [Related]
13. Semisynthetic beta-lactam antibiotics. 6. 1 Sulfocephalosporins and their antipseudomonal activities. Nomura H; Fugono T; Hitaka T; Minami I; Azuma T; Morimoto S; Masuda T J Med Chem; 1974 Dec; 17(12):1312-5. PubMed ID: 4214929 [No Abstract] [Full Text] [Related]
14. Nanomolar inhibitors of AmpC beta-lactamase. Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668 [TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase. Shahid M; Singhai M; Malik A; Shukla I; Khan HM; Shujatullah F; Tahira F J Antimicrob Chemother; 2007 Jul; 60(1):187-8. PubMed ID: 17491002 [No Abstract] [Full Text] [Related]
16. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687 [TBL] [Abstract][Full Text] [Related]
17. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition. Bethel CR; Hujer AM; Helfand MS; Bonomo RA FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726 [TBL] [Abstract][Full Text] [Related]
18. A kinetic study on the interaction between tazobactam (a penicillanic acid sulphone derivative) and active-site serine beta-lactamases. Perilli M; Franceschini N; Bonfiglio G; Segatore B; Stefani S; Nicoletti G; Perez MM; Bianchi C; Zollo A; Amicosante G J Enzyme Inhib; 2000; 15(1):1-10. PubMed ID: 10850951 [TBL] [Abstract][Full Text] [Related]
19. Selective trihydroxyazepane NagZ inhibitors increase sensitivity of Pseudomonas aeruginosa to β-lactams. Mondon M; Hur S; Vadlamani G; Rodrigues P; Tsybina P; Oliver A; Mark BL; Vocadlo DJ; Blériot Y Chem Commun (Camb); 2013 Dec; 49(93):10983-5. PubMed ID: 24136176 [TBL] [Abstract][Full Text] [Related]
20. Comparative activity of beta-lactamase inhibitors combined with beta-lactams against antibiotic-resistant enterobacter. Tejedor-Junco MT; Gonzalez-Martin M; Lupiola PA; Santana OE; Lopez-Orge RH; Gonzalez-Lama Z J Chemother; 1989 Jul; 1(4 Suppl):346-8. PubMed ID: 16312432 [No Abstract] [Full Text] [Related] [Next] [New Search]